Company / Current Assets per Share
Foghorn Therapeutics Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.94
FY2025
5-year range
$2.94 / $8.51
FY2021-FY2025
Trend
-50.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 6 years, ranging from $2.94 in FY2025 to $39.15 in FY2020.
Based on SEC 10-K filings.
2.94 in FY2025 with a 5-year CAGR of -40.4%.
Declined from $5.75 to $2.94 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -29.9%
- 5-Year CAGR
- -40.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 50.3% year-over-year.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.94 | -50.3% |
| FY2024 | $5.90 | +2.7% |
| FY2023 | $5.75 | -32.5% |
| FY2022 | $8.51 | +64.2% |
| FY2021 | $5.18 | -86.8% |
| FY2020 | $39.15 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026